DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Firefly luciferase assay are 26

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_2015	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2016	Tamoxifen	Antineoplastic and Immunomodulating Agents	Breast cancer	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2017	Clemastine	Respiratory System	Allergic rhinitis	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2018	Toremifene	Antineoplastic and Immunomodulating Agents	Breast Cancer	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved, Investigational	26585243
DrugRepV_2019	Paroxetine	Nervous System	Major depressive disorder (MDD) | Panic disorder | Obsessive-compulsive disorder (OCD) | Social anxiety disorder (social phobia) | Generalized anxiety disorder (GAD) | Post-traumatic stress disorder (PTSD) | Premenstrual dysphoric disorder (PMDD)	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved, Investigational	26585243
DrugRepV_2020	Amiodarone	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved, Investigational	26585243
DrugRepV_2021	Clomiphene	Genito Urinary System and Sex Hormones	Cancer	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2022	Securinine	Anticancer	NA	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	NA	26585243
DrugRepV_2023	Glafenine	Nervous System	Inflammatory disease	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	NA	26585243
DrugRepV_2024	Oxeladin	Respiratory-Tract-agents	Cough	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Withdrawn	26585243
DrugRepV_2025	Pimethixene Maleate	Respiratory System	NA	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2026	Artemisinin	Antiparasitic products, Insectisides and Repellents	Malaria	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Experimental	26585243
DrugRepV_2027	Indoprofen	Musculo-Skeletal System	Inflammatory disease	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Withdrawn	26585243
DrugRepV_2028	Iodoquinol	Genito Urinary System and Sex Hormones	Amoebiasis	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2029	Levonordefrin	NA	Dental disorders	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2030	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (90 %)	Approved	26585243
DrugRepV_2031	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (50 %)	Approved	26585243
DrugRepV_2032	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (87.5 %)	Approved	26585243
DrugRepV_2033	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	Decrease (95 %)	Approved	26585243
DrugRepV_2034	Teicoplanin	Antiinfectives For Systemic Use	Bacterial infections	Ebola virus	Zaire strain-pEBOV	NA	Firefly luciferase assay	No significant effect (0 %)	Approved	26585243
DrugRepV_3745	Falnidamol	NA	Solid Tumor	Ebola virus	1976	NA	Firefly luciferase assay	Decrease (50 %)	Investigational	25986249
DrugRepV_3746	Falnidamol	NA	Solid Tumor	Ebola virus	2014	NA	Firefly luciferase assay	Decrease (50 %)	Investigational	25986249
DrugRepV_3747	Falnidamol	NA	Solid Tumor	Lassa virus	NA	NA	Firefly luciferase assay	Decrease (50 %)	Investigational	25986249
DrugRepV_3748	Amiodarone Hydrochloride	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	1976	NA	Firefly luciferase assay	Decrease (50 %)	Approved	25986249
DrugRepV_3749	Amiodarone Hydrochloride	Cardiovascular agents	Anginal and Arrhythmia	Ebola virus	2014	NA	Firefly luciferase assay	Decrease (50 %)	Approved	25986249
DrugRepV_3750	Amiodarone Hydrochloride	Cardiovascular agents	Anginal and Arrhythmia	Lassa virus	NA	NA	Firefly luciferase assay	Decrease (50 %)	Approved	25986249